Company profile
Colonic Drug Delivery | Colon Targeted Drug Delivery | Intract Pharma
Transforming Patient Care by Replacing Injections with Safer, More Effective Therapeutics Given Orally.
Reference milestones and recent Companies House filing stream events.
Next accounts due date
Next confirmation statement due date
Last accounts made up date
Last confirmation statement made up date
AA | Transaction MzQzNDQ3ODU0OGFkaXF6a2N4
Published 04 Sep 2024 11:09
Company registered at Companies House
1 Jan 2024 to 31 Dec 2026
1 Oct 2018 to 30 Sep 2021
Though the monoclonal antibody (mAb), infliximab, is considered a gold-standard treatment for the 300,000 patients in the UK with inflammatory bowel disease (IBD), the compound can only be administered through an inconvenient and often painful injection. In doing so, only less than 1% of the drug reaches the site of disease, limiting the efficacy of the t...
